P16 DELETION AND MUTATION ANALYSIS IN HUMAN BRAIN-TUMORS

Citation
Fg. Barker et al., P16 DELETION AND MUTATION ANALYSIS IN HUMAN BRAIN-TUMORS, Journal of neuro-oncology, 31(1-2), 1997, pp. 17-23
Citations number
33
Categorie Soggetti
Clinical Neurology",Oncology
Journal title
ISSN journal
0167594X
Volume
31
Issue
1-2
Year of publication
1997
Pages
17 - 23
Database
ISI
SICI code
0167-594X(1997)31:1-2<17:PDAMAI>2.0.ZU;2-Z
Abstract
We screened human primary and recurrent malignant glioma, juvenile pil ocytic astrocytoma, medulloblastoma, and meningioma tissue specimens f or alterations in p16 gene structure. Single strand conformation polym orphism (SSCP) analysis was used to screen for point mutations, and a quantitative polymerase chain reaction-based assay was used to screen for homozygous gene deletions. In malignant glioma specimens, homozygo us p16 gene deletions were significantly more common in high-grade tum ors than in low-grade gliomas. Point mutations causing alteration in p redicted protein structure were not detected. Medulloblastomas showed rare homozygous deletions and no point mutations. No mutations were de tected in meningiomas.